Respuesta de Abdel-Qadir et al a la carta sobre el artículo "Sangrado y nuevos diagnósticos malignos después de la anticoagulación para la fibrilación auricular: un estudio de cohorte basado en la población"

¹Temerty Faculty of Medicine (H.A.-Q., K.G.), University of Toronto, Canada.
²Institute of Health Policy, Management, and Evaluation (H.A.-Q., P.C.A., C.A.J., D.S.L.), University of Toronto, Canada.
³Women's College Hospital, Toronto, Canada (H.A.-Q., K.G.).
⁴ICES, Toronto, Canada (H.A.-Q., X.W., P.C.A., C.A.J., D.T.K., D.S.L.).
⁵Department of Medicine, Division of Cardiology, University Health Network, Toronto, Canada (H.A.-Q., D.S.L., P.T.).
⁶Western University of Health Sciences, Pomona, CA (C.A.J.).
⁷Peter Munk Cardiac Centre, Toronto, Canada (I.N.A.).
⁸Cardiology Division, Sheba Medical Center, Ramat Gan, Israel (I.N.A.).
⁹Schulich Heart Centre, Sunnybrook Hospital, Toronto, Canada (D.T.K.).
¹⁰Perelman School of Medicine, University of Pennsylvania, Philadelphia (M.F.).
¹¹Department of Medicine (P.D.), University of Toronto, Canada.
¹²Division of Cardiology, Unity Health, Toronto, Canada (P.D.).

Resumen